Circulation. 2001;104:636-641
doi: 10.1161/hc3101.093701
doi: 10.1161/hc3101.093701
(Circulation. 2001;104:636.)
© 2001 American Heart Association, Inc.
Clinical Investigation and Reports |
Normal Flow (TIMI-3) Before Mechanical Reperfusion Therapy Is an Independent Determinant of Survival in Acute Myocardial Infarction
Analysis From the Primary Angioplasty in Myocardial Infarction Trials
From the Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, NY.
Address reprint requests to Gregg W. Stone, MD, The Cardiovascular Research Foundation, 55 E 59th St, 6th Floor, New York, NY 10022. E-mail gstone{at}crf.org
Background—— Whereas survival after lytic therapy for myocardial infarction is strongly dependent on early administration, it is unknown whether the otherwise excellent outcomes in patients undergoing primary PTCA for acute myocardial infarction, in whom TIMI-3 flow rates of >90% may be achieved, can be further improved by early reperfusion.
Methods and Results—— Among 2507 patients enrolled in 4 PAMI trials undergoing primary PTCA, spontaneous reperfusion (TIMI-3 flow) was present in 16% at initial angiography. Compared with patients without TIMI-3 flow, those with TIMI-3 flow before PTCA had greater left ventricular ejection fraction (57±10% versus 53±11%, P=0.003) and were less likely to present in heart failure (7.0% versus 11.6%, P=0.009). Patients with initial TIMI-3 flow had significantly lower in-hospital rates of mortality, new-onset heart failure, and hypotension and had a shorter hospital stay. Cumulative 6-month mortality was 0.5% in patients with initial TIMI-3 flow, 2.8% with TIMI-2 flow, and 4.4% with initial TIMI-0/1 flow (P=0.009). By multivariate analysis, TIMI-3 flow before PTCA was an independent determinant of survival (odds ratio 2.1, P=0.04), even when corrected for by postprocedural TIMI-3 flow.
Conclusions—— Patients undergoing primary PTCA in whom TIMI-3 flow is present before angioplasty present with greater clinical and angiographic evidence of myocardial salvage, are less likely to develop complications related to left ventricular failure, and have improved early and late survival. These data warrant prospective randomized trials of pharmacological strategies to promote early reperfusion before definitive mechanical intervention in acute myocardial infarction.
Key Words: angioplasty • survival • myocardial infarction • reperfusion
Related Article:
Circulation 2001 104: 624-626.
This article has been cited by other articles:
 |
|
 |
|
  K R Bainey, Y Fu, C B Granger, C W Hamm, D R Holmes Jr, W W O'Neill, R Seabra-Gomes, M E Pfisterer, F Van de Werf, P W Armstrong, et al. Benefit of angiographic spontaneous reperfusion in STEMI: does it extend to diabetic patients? Heart, August 15, 2009; 95(16): 1331 - 1336. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Le May, G. A. Wells, C. A. Glover, D. Y. So, M. Froeschl, J.-F. Marquis, E. R. O'Brien, M. Turek, A. Thomas, M. Kass, et al. Primary Percutaneous Coronary Angioplasty With and Without Eptifibatide in ST-Segment Elevation Myocardial Infarction: A Safety and Efficacy Study of Integrilin-Facilitated Versus Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction (ASSIST) Circ Cardiovasc Interv, August 1, 2009; 2(4): 330 - 338. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-C. Fang, Yeun Tarl Fresner NgJao, Yi Chen, C.-L. Yu, and S.-P. Wang Glycoprotein IIb/IIIa Inhibitor (Tirofiban) in Acute ST-Segment Elevation Myocardial Infarction Angiology, April 1, 2009; 60(2): 192 - 200. [Abstract] [PDF]
|
|
|
|
 |
|
 P. Ortolani, A. Marzocchi, C. Marrozzini, T. Palmerini, F. Saia, N. Taglieri, F. Baldazzi, G. Dall'Ara, P. Nardini, S. Gianstefani, et al. Long-term effectiveness of early administration of glycoprotein IIb/IIIa agents to real-world patients undergoing primary percutaneous interventions: results of a registry study in an ST-elevation myocardial infarction network Eur. Heart J., January 1, 2009; 30(1): 33 - 43. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G De Luca, C M Gibson, F Bellandi, S Murphy, M Maioli, M Noc, U Zeymer, D Dudek, H-R Arntz, S Zorman, et al. Early glycoprotein IIb-IIIa inhibitors in primary angioplasty (EGYPT) cooperation: an individual patient data meta-analysis Heart, December 1, 2008; 94(12): 1548 - 1558. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Vlaar, T. Svilaas, K. Damman, B. J.G.L. de Smet, J. G.P. Tijssen, H. L. Hillege, and F. Zijlstra Impact of Pretreatment With Clopidogrel on Initial Patency and Outcome in Patients Treated With Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction: A Systematic Review Circulation, October 28, 2008; 118(18): 1828 - 1836. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. E. Denktas, H. Athar, T. D. Henry, D. M. Larson, M. Simons, R. S. Chan, N. W. Niles, H. Thiele, G. Schuler, C. Ahn, et al. Reduced-Dose Fibrinolytic Acceleration of ST-Segment Elevation Myocardial Infarction Treatment Coupled With Urgent Percutaneous Coronary Intervention Compared to Primary Percutaneous Coronary Intervention Alone: Results of the AMICO (Alliance for Myocardial Infarction Care Optimization) Registry J. Am. Coll. Cardiol. Intv., October 1, 2008; 1(5): 504 - 510. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Ndrepepa, J. Mehilli, S. Schulz, R. Iijima, D. Keta, R. A. Byrne, J. Pache, M. Seyfarth, A. Schomig, and A. Kastrati Prognostic Significance of Epicardial Blood Flow Before and After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes J. Am. Coll. Cardiol., August 12, 2008; 52(7): 512 - 517. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. W. Stone Angioplasty Strategies in ST-Segment-Elevation Myocardial Infarction: Part II: Intervention After Fibrinolytic Therapy, Integrated Treatment Recommendations, and Future Directions Circulation, July 29, 2008; 118(5): 552 - 566. [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Leopold Does Thrombolytic Therapy Facilitate or Foil Primary PCI? N. Engl. J. Med., May 22, 2008; 358(21): 2277 - 2279. [Full Text] [PDF]
|
|
|
|
|
|
M. A. McDonald, Y. Fu, U. Zeymer, G. Wagner, S. G. Goodman, A. Ross, C. B. Granger, F. Van de Werf, P. W. Armstrong, and for the ASSENT-4 PCI Investigators Adverse outcomes in fibrinolytic-based facilitated percutaneous coronary intervention: insights from the ASSENT-4 PCI electrocardiographic substudy Eur. Heart J., April 1, 2008; 29(7): 871 - 879. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. W. Smalling, G. M. Giesler, V. R. Julapalli, A. E. Denktas, S. M. Sdringola, M. T. Vooletich, J. J. McCarthy, R. N. Bradley, D. E. Persse, B. K. Richter, et al. Pre-Hospital Reduced-Dose Fibrinolysis Coupled With Urgent Percutaneous Coronary Intervention Reduces Time to Reperfusion and Improves Angiographic Perfusion Score Compared With Prehospital Fibrinolysis Alone or Primary Percutaneous Coronary Intervention: Results of the PATCAR Pilot Trial J. Am. Coll. Cardiol., October 16, 2007; 50(16): 1612 - 1614. [Full Text] [PDF]
|
|
|
|
|
|
S. Dobrzycki, P. Kralisz, K. Nowak, P. Prokopczuk, W. Kochman, J. Korecki, B. Poniatowski, J. Zuk, E. Sitniewska, H. Bachorzewska-Gajewska, et al. Transfer with GP IIb/IIIa inhibitor tirofiban for primary percutaneous coronary intervention vs. on-site thrombolysis in patients with ST-elevation myocardial infarction (STEMI): a randomized open-label study for patients admitted to community hospitals Eur. Heart J., October 2, 2007; 28(20): 2438 - 2448. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. E. Boden, K. Eagle, and C. B. Granger Reperfusion Strategies in Acute ST-Segment Elevation Myocardial Infarction: A Comprehensive Review of Contemporary Management Options J. Am. Coll. Cardiol., September 4, 2007; 50(10): 917 - 929. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Kiernan, H. H. Ting, and B. J. Gersh Facilitated percutaneous coronary intervention: current concepts, promises, and pitfalls Eur. Heart J., July 1, 2007; 28(13): 1545 - 1553. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Thiele, M. J. Kappl, A. Linke, S. Erbs, E. Boudriot, A. Lembcke, D. Kivelitz, and G. Schuler Influence of time-to-treatment, TIMI-flow grades, and ST-segment resolution on infarct size and infarct transmurality as assessed by delayed enhancement magnetic resonance imaging Eur. Heart J., June 6, 2007; (2007) ehm173v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-S. Xing, Q.-C. Xing, Y. Zhang, and W. Zhang Effect of serum creatine kinase-MBmass on the early and hierarchical diagnosis of related artery reperfusion in acute myocardial infarction Postgrad. Med. J., June 1, 2007; 83(980): 422 - 425. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Maioli, F. Bellandi, M. Leoncini, A. Toso, and R. P. Dabizzi Randomized Early Versus Late Abciximab in Acute Myocardial Infarction Treated With Primary Coronary Intervention (RELAx-AMI Trial) J. Am. Coll. Cardiol., April 10, 2007; 49(14): 1517 - 1524. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Schomig, G. Ndrepepa, and A. Kastrati Late myocardial salvage: time to recognize its reality in the reperfusion therapy of acute myocardial infarction Eur. Heart J., August 2, 2006; 27(16): 1900 - 1907. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G De Luca, H Suryapranata, and M Chiariello Aspiration thrombectomy and primary percutaneous coronary intervention Heart, July 1, 2006; 92(7): 867 - 869. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Halkin, G. W. Stone, C. L. Grines, D. A. Cox, B. D. Rutherford, P. Esente, C. M. Meils, P. Albertsson, A. Farah, J. E. Tcheng, et al. Prognostic Implications of Creatine Kinase Elevation After Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction J. Am. Coll. Cardiol., March 7, 2006; 47(5): 951 - 961. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B R Brodie Facilitated percutaneous coronary intervention Heart, December 1, 2005; 91(12): 1527 - 1529. [Full Text] [PDF]
|
|
|
|
|
|
E J Smith, A Mathur, and M T Rothman Recent advances in primary percutaneous intervention for acute myocardial infarction Heart, December 1, 2005; 91(12): 1533 - 1536. [Full Text] [PDF]
|
|
|
|
 |
|
 G. Ndrepepa, A. Kastrati, M. Schwaiger, J. Mehilli, C. Markwardt, A. Dibra, J. Dirschinger, and A. Schomig Relationship Between Residual Blood Flow in the Infarct-Related Artery and Scintigraphic Infarct Size, Myocardial Salvage, and Functional Recovery in Patients with Acute Myocardial Infarction J. Nucl. Med., November 1, 2005; 46(11): 1782 - 1788. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Zeymer, R. Zahn, R. Schiele, W. Jansen, E. Girth, A. Gitt, K. Seidl, R. Schroder, S. Schneider, and J. Senges Early eptifibatide improves TIMI 3 patency before primary percutaneous coronary intervention for acute ST elevation myocardial infarction: results of the randomized integrilin in acute myocardial infarction (INTAMI) pilot trial Eur. Heart J., October 1, 2005; 26(19): 1971 - 1977. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Thiele, L. Engelmann, K. Elsner, M. J. Kappl, W.-H. Storch, K. Rahimi, A. Hartmann, D. Pfeiffer, G. D. Kneissl, D. Schneider, et al. Comparison of pre-hospital combination-fibrinolysis plus conventional care with pre-hospital combination-fibrinolysis plus facilitated percutaneous coronary intervention in acute myocardial infarction Eur. Heart J., October 1, 2005; 26(19): 1956 - 1963. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. W. Armstrong Moving proximally through the intersection between the process and the content of care in ST-elevation myocardial infarction Eur. Heart J., October 1, 2005; 26(19): 1937 - 1938. [Full Text] [PDF]
|
|
|
|
 |
|
 F. Beygui and G. Montalescot The use of GP IIb/IIIa inhibitors into new perspectives: pre-catheterization laboratory administration Eur. Heart J. Suppl., October 1, 2005; 7(suppl_I): I10 - I14. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Le May, G. A. Wells, M. Labinaz, R. F. Davies, M. Turek, D. Leddy, J. Maloney, T. McKibbin, B. Quinn, R. S. Beanlands, et al. Combined Angioplasty and Pharmacological Intervention Versus Thrombolysis Alone in Acute Myocardial Infarction (CAPITAL AMI Study) J. Am. Coll. Cardiol., August 2, 2005; 46(3): 417 - 424. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Gibbons and C. L. Grines Acute PCI for ST-Segment Elevation Myocardial Infarction: Is Later Better Than Never? JAMA, June 15, 2005; 293(23): 2930 - 2932. [Full Text] [PDF]
|
|
|
|
|
|
P. Wenaweser, C. Rey, F. R. Eberli, M. Togni, D. Tuller, S. Locher, A. Remondino, C. Seiler, O. M. Hess, B. Meier, et al. Stent thrombosis following bare-metal stent implantation: success of emergency percutaneous coronary intervention and predictors of adverse outcome Eur. Heart J., June 2, 2005; 26(12): 1180 - 1187. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. Gersh, G. W. Stone, H. D. White, and D. R. Holmes Jr Pharmacological Facilitation of Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction: Is the Slope of the Curve the Shape of the Future? JAMA, February 23, 2005; 293(8): 979 - 986. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Brogren, L. Karlsson, M. Andersson, L. Wang, D. Erlinge, and S. Jern Platelets synthesize large amounts of active plasminogen activator inhibitor 1 Blood, December 15, 2004; 104(13): 3943 - 3948. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Writing Committee Members, E. M. Antman, D. T. Anbe, P. W. Armstrong, E. R. Bates, L. A. Green, M. Hand, J. S. Hochman, H. M. Krumholz, F. G. Kushner, et al. ACC/AHA guidelines for the management of patients with ST-Elevation myocardial infarction--executive summary: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (writing committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction) J. Am. Coll. Cardiol., August 4, 2004; 44(3): 671 - 719. [Full Text] [PDF]
|
|
|
|
|
|
E. M. Antman, D. T. Anbe, P. W. Armstrong, E. R. Bates, L. A. Green, M. Hand, J. S. Hochman, H. M. Krumholz, F. G. Kushner, G. A. Lamas, et al. ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction) Circulation, August 3, 2004; 110(5): 588 - 636. [Full Text] [PDF]
|
|
|
|
|
|
G. Montalescot, M. Borentain, L. Payot, J. P. Collet, and D. Thomas Early vs Late Administration of Glycoprotein IIb/IIIa Inhibitors in Primary Percutaneous Coronary Intervention of Acute ST-Segment Elevation Myocardial Infarction: A Meta-analysis JAMA, July 21, 2004; 292(3): 362 - 366. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. J. Buttner and F.-J. Neumann Tirofiban for catheter intervention in acute myocardial infarction? Eur. Heart J., May 2, 2004; 25(10): 807 - 809. [Full Text] [PDF]
|
|
|
|
|
|
A. W.J van't Hof, N. Ernst, M.-J. de Boer, R. de Winter, E. Boersma, T. Bunt, S. Petronio, A.T Marcel Gosselink, W. Jap, F. Hollak, et al. Facilitation of primary coronary angioplasty by early start of a glycoprotein 2b/3a inhibitor: results of the ongoing tirofiban in myocardial infarction evaluation (On-TIME) trial Eur. Heart J., May 2, 2004; 25(10): 837 - 846. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T. Roe, C. L. Green, R. P. Giugliano, C. M. Gibson, K. Baran, M. Greenberg, S. T. Palmeri, S. Crater, K. Trollinger, K. Hannan, et al. Improved speed and stability of st-segment recovery with reduced-dose tenecteplase and eptifibatide compared with full-dose tenecteplase for acute st-segment elevation myocardial infarction J. Am. Coll. Cardiol., February 18, 2004; 43(4): 549 - 556. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. A. Sanborn, L. A. Sleeper, J. G. Webb, J. K. French, G. Bergman, M. Parikh, S. C. Wong, J. Boland, M. Pfisterer, J. N. Slater, et al. Correlates of one-year survival inpatients with cardiogenic shock complicating acute myocardial infarction: Angiographic findings from the SHOCK trial J. Am. Coll. Cardiol., October 15, 2003; 42(8): 1373 - 1379. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Tcheng, D. E. Kandzari, C. L. Grines, D. A. Cox, M. B. Effron, E. Garcia, J. J. Griffin, G. Guagliumi, T. Stuckey, M. Turco, et al. Benefits and Risks of Abciximab Use in Primary Angioplasty for Acute Myocardial Infarction: The Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial Circulation, September 16, 2003; 108(11): 1316 - 1323. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. G. McKay Evolving strategies in the treatment of acute myocardial infarction in the community hospital setting J. Am. Coll. Cardiol., August 20, 2003; 42(4): 642 - 645. [Full Text] [PDF]
|
|
|
|
|
|
H. L. Dauerman and B. E. Sobel Synergistic treatment of ST-segmentelevation myocardial infarction with pharmacoinvasive recanalization J. Am. Coll. Cardiol., August 20, 2003; 42(4): 646 - 651. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Iwakura, H. Ito, S. Kawano, A. Okamura, K. Asano, T. Kuroda, K. Tanaka, T. Masuyama, M. Hori, and K. Fujii Detection of TIMI-3 Flow Before Mechanical Reperfusion With Ultrasonic Tissue Characterization in Patients With Anterior Wall Acute Myocardial Infarction Circulation, July 1, 2003; 107(25): 3159 - 3164. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. L. Grines, P. Serruys, and W. W. O'Neill Fibrinolytic Therapy: Is It A Treatment of the Past? Circulation, May 27, 2003; 107(20): 2538 - 2542. [Full Text] [PDF]
|
|
|
|
|
|
J. P.S. Henriques, F. Zijlstra, A. W.J. van 't Hof, M.-J. de Boer, J.-H. E. Dambrink, M. Gosselink, J. C.A. Hoorntje, and H. Suryapranata Angiographic Assessment of Reperfusion in Acute Myocardial Infarction by Myocardial Blush Grade Circulation, April 29, 2003; 107(16): 2115 - 2119. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. P. Giugliano, M. T. Roe, R. A. Harrington, C. M. Gibson, U. Zeymer, F. Van de Werf, K. W. Baran, H.-P. Hobbach, L. H. Woodlief, K. L. Hannan, et al. Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation myocardial infarction: Results of the integrilin and tenecteplase in acute myocardial infarction (INTEGRITI) Phase II Angiographic urial J. Am. Coll. Cardiol., April 16, 2003; 41(8): 1251 - 1260. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. S. Kleiman Combination therapy for acute myocardial infarction: Will it survive? J. Am. Coll. Cardiol., April 16, 2003; 41(8): 1261 - 1263. [Full Text] [PDF]
|
|
|
|
|
|
D. P. Lee, N. A. Herity, B. L. Hiatt, W. F. Fearon, M. Rezaee, A. J. Carter, M. Huston, D. Schreiber, P. M. DiBattiste, and A. C. Yeung Adjunctive Platelet Glycoprotein IIb/IIIa Receptor Inhibition With Tirofiban Before Primary Angioplasty Improves Angiographic Outcomes: Results of the TIrofiban Given in the Emergency Room before Primary Angioplasty (TIGER-PA) Pilot Trial Circulation, March 25, 2003; 107(11): 1497 - 1501. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Balcells, E. R. Powers, W. Lepper, T. Belcik, K. Wei, M. Ragosta, H. Samady, and J. R. Lindner Detection of myocardial viability by contrast echocardiography in acute infarction predicts recovery of resting function and contractile reserve J. Am. Coll. Cardiol., March 5, 2003; 41(5): 827 - 833. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D Rimar, E Crystal, A Battler, S Gottlieb, D Freimark, H Hod, V Boyko, L Mandelzweig, S Behar, and J Leor Improved prognosis of patients presenting with clinical markers of spontaneous reperfusion during acute myocardial infarction Heart, October 1, 2002; 88(4): 352 - 356. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Allaqaband and T. K. Bajwa "Time Is Muscle" Only in Experienced Hands and High-Volume Centers J Intensive Care Med, July 1, 2002; 17(4): 199 - 201. [PDF]
|
|
|
|
|
|
C. L. Grines, D. R. Westerhausen Jr, L. L. Grines, J. T. Hanlon, T. L. Logemann, M. Niemela, W. D. Weaver, M. Graham, J. Boura, W. W. O'Neill, et al. A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction: The air primary angioplasty in myocardial infarction study J. Am. Coll. Cardiol., June 5, 2002; 39(11): 1713 - 1719. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Zijlstra, N. Ernst, M.-J. de Boer, E. Nibbering, H. Suryapranata, J. C. A. Hoorntje, J.-H. E. Dambrink, A. W. J. van't Hof, and F. W. A. Verheugt Influence of prehospital administration of aspirin and heparin on initial patency of the infarct-related artery in patients with acute st elevation myocardial infarction J. Am. Coll. Cardiol., June 5, 2002; 39(11): 1733 - 1737. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. P. Cannon Primary Percutaneous Coronary Intervention for All? JAMA, April 17, 2002; 287(15): 1987 - 1989. [Full Text] [PDF]
|
|
|
|
|
|
G. W. Stone, C. L. Grines, D. A. Cox, E. Garcia, J. E. Tcheng, J. J. Griffin, G. Guagliumi, T. Stuckey, M. Turco, J. D. Carroll, et al. Comparison of Angioplasty with Stenting, with or without Abciximab, in Acute Myocardial Infarction N. Engl. J. Med., March 28, 2002; 346(13): 957 - 966. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Early Reperfusion Improves PTCA Outcomes for Acute-MI Patients Journal Watch Cardiology, October 12, 2001; 2001(1012): 8 - 8. [Full Text]
|
|
|
|
|
|
C. P. Cannon Importance of TIMI 3 Flow Circulation, August 7, 2001; 104(6): 624 - 626. [Full Text] [PDF]
|
|